Author Correction: A new therapy against ulcerative colitis via the intestine and brain using the Si-based agent

Sci Rep. 2022 Sep 7;12(1):15150. doi: 10.1038/s41598-022-19609-3.

Yoshihisa Koyama^{1

2}, Yuki Kobayashi³, Ikuei Hirota⁴, Yuanjie Sun⁴, Iwao Ohtsu^{5

6}, Hiroe Imai⁷, Yoshichika Yoshioka^{8

9

10}, Hiroto Yanagawa⁴, Takuya Sumi^{4

11}, Hikaru Kobayashi³, Shoichi Shimada^{4

12}

¹ Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. [email protected].
² Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka, 541-8567, Japan. [email protected].
³ SANKEN, Osaka University, Osaka, 567-0047, Japan.
⁴ Department of Neuroscience and Cell Biology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
⁵ University of Tsukuba, Faculty of Life and Environmental Sciences, 108-2, Cooperative Research Building A, Ibaraki, 305-8577, Japan.
⁶ Euglena Co., Ltd., Tokyo, 408-0014, Japan.
⁷ University of Tsukuba, R&D Center for Tailor-Made-QOL, 108-2, Cooperative Research Building A, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8577, Japan.
⁸ Graduate School of Frontier Biosciences, Osaka University, Osaka, 565-0871, Japan.
⁹ Center for Information and Neural Networks, National Institute of Information and Communications Technology (NICT) and Osaka University, Osaka, 565-0871, Japan.
¹⁰ Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, 565-0871, Japan.
¹¹ Department of Cell Biology, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan.
¹² Addiction Research Unit, Osaka Psychiatric Research Center, Osaka Psychiatric Medical Center, Osaka, 541-8567, Japan.

No abstract available

Publication types